Michael M. Morgen

841 total citations
19 papers, 662 citations indexed

About

Michael M. Morgen is a scholar working on Pharmaceutical Science, Analytical Chemistry and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael M. Morgen has authored 19 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmaceutical Science, 5 papers in Analytical Chemistry and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael M. Morgen's work include Drug Solubulity and Delivery Systems (12 papers), Advanced Drug Delivery Systems (8 papers) and Analytical Methods in Pharmaceuticals (5 papers). Michael M. Morgen is often cited by papers focused on Drug Solubulity and Delivery Systems (12 papers), Advanced Drug Delivery Systems (8 papers) and Analytical Methods in Pharmaceuticals (5 papers). Michael M. Morgen collaborates with scholars based in United States, Switzerland and India. Michael M. Morgen's co-authors include D. Vodak, Aaron M. Stewart, Michael Graß, Dwayne T. Friesen, Deanna M. Mudie, Aaron K. Goodwin, John M. Baumann, Kimberly B. Shepard, Akintunde Bello and Rick C. Steenwyk and has published in prestigious journals such as Advanced Drug Delivery Reviews, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Michael M. Morgen

18 papers receiving 643 citations

Peers

Countries citing papers authored by Michael M. Morgen

Since Specialization

Citations

This map shows the geographic impact of Michael M. Morgen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael M. Morgen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael M. Morgen more than expected).

Fields of papers citing papers by Michael M. Morgen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael M. Morgen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael M. Morgen. The network helps show where Michael M. Morgen may publish in the future.

Co-authorship network of co-authors of Michael M. Morgen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael M. Morgen. A scholar is included among the top collaborators of Michael M. Morgen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael M. Morgen. Michael M. Morgen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Experimental and theoretical investigation of rotary atomization dynamics for control of microparticle size during spray congealing process 2023 ·Powder Technology ·(unknown), (unknown), John M. Baumann, Michael M. Morgen	5
2	Predicting Spray Dried Dispersion Particle Size Via Machine Learning Regression Methods 2022 ·Pharmaceutical Research ·John Schmitt, John M. Baumann, Michael M. Morgen	17
3	Acetic Acid as Processing Aid Dramatically Improves Organic Solvent Solubility of Weakly Basic Drugs for Spray Dried Dispersion Manufacture 2022 ·Pharmaceutics ·(unknown), Warren K. Miller, (unknown), Aaron M. Stewart, Jonathan L. Cape, Michael Graß, Michael M. Morgen	7
4	In Vitro-In Silico Tools for Streamlined Development of Acalabrutinib Amorphous Solid Dispersion Tablets 2021 ·Pharmaceutics ·Deanna M. Mudie, Aaron M. Stewart, (unknown), (unknown), Michael M. Morgen, D. Vodak	6
5	Amorphous Solid Dispersion Tablets Overcome Acalabrutinib pH Effect in Dogs 2021 ·Pharmaceutics ·Deanna M. Mudie, Aaron M. Stewart, (unknown), (unknown), (unknown), Adam J. Smith, (unknown), Michael M. Morgen, D. Vodak	6
6	A novel architecture for achieving high drug loading in amorphous spray dried dispersion tablets 2020 ·International Journal of Pharmaceutics X ·Deanna M. Mudie, (unknown), Aaron M. Stewart, Adam J. Smith, Kimberly B. Shepard, (unknown), (unknown), (unknown), (unknown), (unknown), Michael M. Morgen, John M. Baumann, D. Vodak	37
7	Solvent-Assisted Secondary Drying of Spray-Dried Polymers 2020 ·Pharmaceutical Research ·Kimberly B. Shepard, (unknown), (unknown), Michael M. Morgen, John M. Baumann, D. Vodak	13
8	Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions 2020 ·Molecular Pharmaceutics ·Na Li, Jonathan L. Cape, (unknown), Dmitry Zemlyanov, Kimberly B. Shepard, Michael M. Morgen, Lynne S. Taylor	44
9	Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole; In Vivo and In Vitro Assessment 2020 ·Molecular Pharmaceutics ·Deanna M. Mudie, Aaron M. Stewart, (unknown), (unknown), Kimberly B. Shepard, Adam J. Smith, Michael M. Morgen, John M. Baumann, D. Vodak	30
10	Unlocking the full potential of lipid-based formulations using lipophilic salt/ionic liquid forms 2019 ·Advanced Drug Delivery Reviews ·Hywel D. Williams, Leigh Ford, Annabel Igonin, (unknown), Paolo Botti, Michael M. Morgen, (unknown), Colin W. Pouton, Peter J. Scammells, Christopher J. H. Porter, Hassan Benameur	40
11	Impact of process parameters on particle morphology and filament formation in spray dried Eudragit L100 polymer 2019 ·Powder Technology ·Kimberly B. Shepard, (unknown), Michael M. Morgen, Deanna M. Mudie, (unknown), John M. Baumann, D. Vodak	14
12	Mechanistic Study of Belinostat Oral Absorption From Spray-Dried Dispersions 2018 ·Journal of Pharmaceutical Sciences ·Aaron M. Stewart, I.C. Yates, Deanna M. Mudie, (unknown), Aaron K. Goodwin, (unknown), (unknown), Michael M. Morgen, D. Vodak	16
13	Lipophilic salts of poorly soluble compounds to enable high-dose lipidic SEDDS formulations in drug discovery 2017 ·European Journal of Pharmaceutics and Biopharmaceutics ·Michael M. Morgen, (unknown), Xueqing Chen, Warren K. Miller, (unknown), Aaron K. Goodwin, (unknown), Roy Haskell, Ching Su, Olafur Gudmundsson, Michael J. Hageman, Anoop Kumar, (unknown), (unknown), Vinay K. Holenarsipur	47
14	Development of a Biorelevant, Material-Sparing Membrane Flux Test for Rapid Screening of Bioavailability-Enhancing Drug Product Formulations 2017 ·Molecular Pharmaceutics ·Aaron M. Stewart, Michael Graß, Deanna M. Mudie, Michael M. Morgen, Dwayne T. Friesen, D. Vodak	56
15	Impact of Drug-Rich Colloids of Itraconazole and HPMCAS on Membrane Flux in Vitro and Oral Bioavailability in Rats 2017 ·Molecular Pharmaceutics ·Aaron M. Stewart, Michael Graß, (unknown), Aaron K. Goodwin, Michael M. Morgen, Dwayne T. Friesen, D. Vodak	106
16	Amorphous drug-polymer nanoparticles: An enabling drug delivery platform 2014 ·Pharmaceutica Analytica Acta ·Michael M. Morgen	0
17	Nanoparticles for Improved Local Retention after Intra-Articular Injection into the Knee Joint 2012 ·Pharmaceutical Research ·Michael M. Morgen, David Tung, Britton Boras, (unknown), Anne‐Marie Malfait, Micky D. Tortorella	73
18	Targeted delivery of a poorly water-soluble compound to hair follicles using polymeric nanoparticle suspensions 2011 ·International Journal of Pharmaceutics ·Michael M. Morgen, Guang Wei Lu, (unknown), Randall G. Stehle, (unknown), Jessica Cervantes, Susan Ciotti, Roy Haskell, (unknown), Kevin J. Haley, (unknown)	30
19	Polymeric Nanoparticles for Increased Oral Bioavailability and Rapid Absorption Using Celecoxib as a Model of a Low-Solubility, High-Permeability Drug 2011 ·Pharmaceutical Research ·Michael M. Morgen, (unknown), (unknown), Akintunde Bello, Wei Song, Karen F. Wilkinson, Rick C. Steenwyk, Sheri L. Shamblin	115

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact